Lilly can use the technology on up to four of its compounds
doi: 10.3389/fnut.2025.1615671 Received 21 April 2025 Accepted 29 July 2025 Published 13 August 2025 Volume 12 - 2025 Edited by Ismael San Mauro Martn, CINUSA Group, Spain Reviewed by Simone Birgit Bayer, University of Otago, Christchurch, New Zealand Emanuela Ribichini, Sapienza University of Rome, Italy Aleksandar Sic, Advocate Illinois Masonic Medical Center, United States Updates Copyright 2025 Khan, Brnstad, Hillestad, Steinsvik, Hausken, Berentsen and Lied
2,3,4,5 This review explores the current data on cardiovascular effects and potential advantages of GLP-1RA therapy in patients with HFpEF
Risks & Side Effects Risks & Side Effects of GLP-1 Peptide Therapy As with any medical treatment, GLP-1 weight loss therapy may cause side effects that vary in type, duration, and severity for each patient
It typically has fewer gastrointestinal side effects than Semaglutide GLP-1 and a lower risk of pancreatitis